Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||- / 1||- / -|
Administered by: Other Purchased by: ??
Symptoms: Abdominal pain, SARS-CoV-2 test
Life Threatening? No
Birth Defect? No
Permanent Disability? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Preexisting Conditions: Medical History/Concurrent Conditions: Suspected COVID-19
Diagnostic Lab Data: Test Date: 20210108; Test Name: COVID-19 virus test; Test Result: Positive ; Comments: Yes - Positive COVID-19 test
CDC 'Split Type': GBPFIZER INC2021657976
Write-up: Abdominal pain; This is a spontaneous report from a contactable consumer received from the regulatory authority (RA). The regulatory authority report number is GB-MHRA-WEBCOVID-202106050812260430-UG8VW Safety Report Unique Identifier GB-MHRA-ADR 25425149. A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 02Jun2021 (Lot number was not reported) as single dose for COVID-19 immunisation. Medical history included suspected covid-19 from 03Jan2021 to 14Jan2021. Patient is not enrolled in clinical trial. The patient''s concomitant medications were not reported. The patient experienced severe abdominal pain (disability) on 03Jun2021. The patient underwent lab tests and procedures which included COVID-19 virus test: positive (Yes - Positive COVID-19 test) on 08Jan2021. Outcome of the event was not recovered. No follow-up attempts are possible. Information about batch no cannot be obtained.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166